News
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine, but limited its use to older adults and people ...
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...
The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...
The spring vaccination programme began on Tuesday, April 1 and almost half a million vaccinations have been delivered so far.
Kennedy’s FDA approved the use of the Novavax Covid-19 vaccine, but with strict conditions. It will only be made available to older people and those over the age of 12 with at least one medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results